Medical Research: Federal Investments to Improve Public Health and the Nation's Economy : Hearing Before the Task Force on Human Resources of the Committee on the Budget, House of Representatives, One Hundred Second Congress, Second Session, Hearing Held in Washington, DC, September 23, 1992, 4. sējumsU.S. Government Printing Office, 1992 - 63 lappuses |
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
Alzheimer's disease American aminoglutethimide applications biology biomedical research enterprise biotechnology blood brain breast cancer budget cancer cells cause Chairman OBERSTAR challenges Characterization chemotherapy CLARKE Clinical Center clinical trial Cloning Committee Congress cure cystic fibrosis cystic fibrosis gene declined Demonstration detection Discovery disorder drug economic effective Federal Forman funding future gene therapy genetic Genome going HEALY hearing heart hormone human Identification immunotherapy important individual infection inherited Institutes of Health investment KOHN laboratory Liotta Lovastatin lung major malignant mammography mechanisms medical research medicine ment million mission molecular mutations National Cancer Institute National Institutes needs NIH Intramural Program NIH's Nobel Prize normal opportunity ovarian cancer patients percent prevention priority projects prostate cancer protein public health receptor response Rosenberg scientific scientists senior strategic plan studies suramin surgery Tamoxifen target task force Taxol Thank treat treatment tumor vaccine virus women Women's Health Initiative